NORTH RUN CAPITAL, LP - Q1 2022 holdings

$68 Million is the total value of NORTH RUN CAPITAL, LP's 21 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was - .

 Value Shares↓ Weighting
NewMAXCYTE INC$3,361,000480,900
+100.0%
4.94%
SUMO NewSUMO LOGIC INC$2,429,000208,100
+100.0%
3.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BROOKDALE SR LIVING INC39Q4 202219.4%
MAGNACHIP SEMICONDUCTOR CORP31Q4 202214.6%
NEW YORK & CO INC20Q1 20183.7%
CONSTELLIUM SE18Q3 201912.0%
LORAL SPACE & COMMUNICATNS I18Q4 20205.4%
CHARAH SOLUTIONS INC15Q3 202212.3%
PEGASYSTEMS INC15Q4 20226.9%
ALIMERA SCIENCES INC15Q4 20161.6%
PSIVIDA CORP15Q4 20161.1%
INVACARE CORP14Q4 20223.8%

View NORTH RUN CAPITAL, LP's complete holdings history.

Latest significant ownerships (13-D/G)
NORTH RUN CAPITAL, LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
LENSAR, Inc.May 19, 20231,100,5929.9%
AIRGAIN INCFebruary 13, 2023395,8013.9%
Charah Solutions, Inc.February 13, 202392,5202.7%
SAFEGUARD SCIENTIFICS INCFebruary 13, 2023252,7281.5%
Charah Solutions, Inc.February 14, 20222,137,5006.4%
Internap CorpFebruary 12, 2020400,0001.5%
Constellium N.V.February 09, 20181,300,0001.0%
MAGNACHIP SEMICONDUCTOR CorpFebruary 09, 20181,130,0003.3%
New York & Company, Inc.February 09, 2018900,3511.4%
ALIMERA SCIENCES INCFebruary 10, 20171,730,0002.7%

View NORTH RUN CAPITAL, LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-21
32024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
32023-06-06
SC 13D2023-05-19
13F-HR2023-02-14
SC 13G/A2023-02-13
SC 13G/A2023-02-13
SC 13G/A2023-02-13

View NORTH RUN CAPITAL, LP's complete filings history.

Compare quarters

Export NORTH RUN CAPITAL, LP's holdings